MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, OMI made $697,264,000 in revenue. -$150,276,000 in net income. Net profit margin of -21.55%.

Income Overview

Revenue
$697,264,000
Net Income
-$150,276,000
Net Profit Margin
-21.55%
EPS
-$1.94
Unit: Dollar
Revenue Breakdown
    • Diabetes Product
    • Sleep Therapy Product
    • Home Respiratory Therapy Product
    • Others
Revenue Breakdown
    • Commercial Payors
    • Medicare
    • Medicaid

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net revenue
697,264,000 681,917,000 2,632,048,000 2,654,376,000
Cost of net revenue
375,067,000 357,315,000 2,106,035,000 2,096,728,000
Gross profit
--526,013,000 557,648,000
Selling, general and administrative expenses
265,838,000 267,853,000 462,352,000 408,562,000
Transaction breakage fee
-80,000,000 --
Other operating expense (income), net
---2,637,000 3,837,000
Acquisition-related charges and intangible amortization
29,229,000 13,918,000 29,674,000 22,730,500
Exit and realignment charges, net
660,000 2,541,000 31,226,000 25,994,500
Goodwill impairment charge
---76,778,000
Total operating costs and expenses
670,794,000 721,627,000 --
Loss (gain) on extinguishment of debt
----275,250
Operating income
26,470,000 -39,710,000 124,000 -126,136,000
Interest expense, net
29,029,000 26,009,000 33,959,000 35,675,500
Transaction financing fees, net
-18,288,000 --
Other expense, net
-1,076,000 -942,000 -1,239,000 -1,020,000
(loss) income from continuing operations before income taxes
-3,635,000 -84,949,000 -35,074,000 -163,382,000
Income tax provision (benefit)
1,972,000 -1,127,000 -10,092,000 -4,380,500
(loss) income from continuing operations, net of tax
-5,607,000 -83,822,000 --
Net revenue
2,007,078,000 ---
Cost of goods sold
1,818,935,000 ---
Gross profit
188,143,000 ---
Distribution, selling, and administrative expenses
186,885,000 ---
Exit and realignment charges, net
25,122,000 ---
Loss on classification to held for sale
122,500,000 ---
Other operating expense, net
2,217,000 ---
Operating (loss) income
-148,581,000 ---
Interest expense, net
-7,636,000 ---
Other expense
269,000 ---
Loss from discontinued operations before income taxes
-156,486,000 ---
Income tax (benefit) provision for discontinued operations
-11,817,000 ---
Loss from discontinued operations, net of tax
-144,669,000 -785,236,000 --
Net loss
-150,276,000 -869,058,000 -24,982,000 -159,001,500
Earnings per share, basic
-1.94 -11.3 -0.32 -2.07
Earnings per share, diluted
-1.94 -11.3 -0.32 -2.07
Weighted average number of shares outstanding, basic
77,288,000 76,935,000 77,272,000 -38,538,000
Weighted average number of shares outstanding, diluted
77,288,000 76,935,000 77,272,000 -38,538,000
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$150,276,000 Product And ServiceOther$72,586,000 Urology$28,976,000 Wound Care$48,001,000 Ostomy$53,274,000 Home RespiratoryTherapy Product$107,256,000 Sleep Therapy Product$185,799,000 Diabetes Product$201,372,000 Loss fromdiscontinued operations, net...-$144,669,000 (loss) income fromcontinuing operations, net...-$5,607,000 Income tax (benefit)provision for...-$11,817,000 Net revenue$697,264,000 Loss fromdiscontinued operations...-$156,486,000 Income tax provision(benefit)$1,972,000 (loss) income fromcontinuing operations...-$3,635,000 Operating income$26,470,000 Net revenue$2,007,078,000 Total operating costsand expenses$670,794,000 Other expense$269,000 Interest expense, net-$7,636,000 Operating (loss) income-$148,581,000 Other expense, net-$1,076,000 Interest expense, net$29,029,000 Other operatingexpense, net$2,217,000 Gross profit$188,143,000 Cost of goods sold$1,818,935,000 Exit and realignmentcharges, net$660,000 Acquisition-related charges andintangible amortization$29,229,000 Selling, general andadministrative expenses$265,838,000 Cost of net revenue$375,067,000 Loss onclassification to held for sale$122,500,000 Exit and realignmentcharges, net$25,122,000 Distribution, selling, andadministrative expenses$186,885,000

OWENS & MINOR INC VA (OMI)

OWENS & MINOR INC VA (OMI)